Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

BACKGROUND AND PURPOSE: Angiotensin AT (2) receptors are upregulated in disease states such as atherosclerosis and blockade of the AT(2) receptors exacerbates plaque formation. Direct stimulation of these receptors is anti‐atherogenic but the mechanisms and pathways involved remain unknown. We exami...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Pharmacol
Hoofdauteurs: Sampson, Amanda K, Irvine, Jennifer C, Shihata, Waled A, Dragoljevic, Dragana, Lumsden, Natalie, Huet, Olivier, Barnes, Tyrone, Unger, Thomas, Steckelings, Ulrike M, Jennings, Garry L, Widdop, Robert E, Chin‐Dusting, Jaye P F
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2015
Onderwerpen:
Themed Section: Research Papers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742292/
https://ncbi.nlm.nih.gov/pubmed/25560767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13063
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items